Hyperprolactinemia

DBCOND0000952Endocrine System Diseases

Hyperprolactinemia is the indication for 3 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Hyperprolactinaemia · hyperprolactinemic disorder
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0010850ICD-10E22.1SNOMED CT190468001MedDRA10020737UMLSC0020514

What you can answer from here — as of November 06, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
26Clinical trialsPhase, status and sponsor resolved per trial
Sign in
25Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hyperprolactinemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In